Filing Details
- Accession Number:
- 0001127602-24-009301
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-11 08:59:08
- Reporting Period:
- 2024-03-07
- Accepted Time:
- 2024-03-11 08:59:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1793112 | S Mark Schroeder | 531 South Spring Street Burlington NC 27215 | Evp, Pres Diagnostics & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-03-07 | 2,119 | $117.09 | 10,084 | No | 4 | M | Direct | |
Common Stock | Disposition | 2024-03-07 | 5,048 | $218.45 | 5,036 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Options | Disposition | 2024-03-07 | 2,119 | $0.00 | 2,119 | $117.09 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2018-02-07 | 2027-02-06 | No | 4 | M | Direct |
Footnotes
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
- Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"),calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea.
- The option vested in three equal annual installments beginning on the date reflected in this column.